首页> 美国卫生研究院文献>Annals of the Rheumatic Diseases >Adalimumab alone and in combination with disease‐modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial

【2h】

Adalimumab alone and in combination with disease‐modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial

机译：在临床实践中单独使用阿达木单抗或与抗风湿病药物联合用于治疗类风湿关节炎：活动性类风湿关节炎研究（ReAct）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveTo evaluate the safety and effectiveness of adalimumab alone or in combination with standard disease‐modifying antirheumatic drugs (DMARDs) for the treatment of rheumatoid arthritis (RA).

机译：目的评估单独使用阿达木单抗或与标准的能缓解疾病的抗风湿药（DMARDs）组合治疗类风湿关节炎（RA）的安全性和有效性。

著录项

期刊名称 Annals of the Rheumatic Diseases
作者
Gerd R Burmester; Xavier Mariette; Carlomaurizio Montecucco; Indalecio Monteagudo‐Sáez; Michel Malaise; Athanasios G Tzioufas; Johannes W J Bijlsma; Kristina Unnebrink; Sonja Kary; Hartmut Kupper;
展开▼
作者单位

展开▼
年(卷),期 2007(66),6
年度 2007
页码 732–739
总页数 8
原文格式 PDF
正文语种
中图分类免疫性疾病;
关键词
adalimumab rheumatoid arthritis tumour necrosis factor monoclonal antibody antirheumatic agents;

机译：阿达木单抗;类风湿关节炎;肿瘤坏死因子;单克隆抗体;抗风湿药;

相似文献

外文文献
中文文献
专利

1. Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial. [J] . Rantalaiho V, Korpela M, Laasonen L, Arthritis research & therapy. . 2010,第3期

机译：早期组合疾病改良抗风湿药治疗和严格的疾病控制改善了早期类风湿关节炎患者的长期放射学结果：芬兰类风湿关节炎联合疗法试验的11年结果。
2. Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial [J] . Vappu Rantalaiho, Markku Korpela, Leena Laasonen, Arthritis Research . 2010,第3期

机译：早期组合疾病改良抗风湿药物治疗和严格的疾病控制改善了早期类风湿关节炎患者的长期放射学结局：芬兰类风湿关节炎联合疗法试验的11年结果
3. Adalimumab, etanercept, infliximab,certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional disease-modifying antirheumatic drugs only: systematic review and economic evaluation [J] . Stevenson?M, Archer?R, Tosh?J, Health technology assessment: HTA . 2016,第35期

机译：阿达木单抗，依那西普，英夫利昔单抗，赛妥珠单抗，聚乙二醇，戈利木单抗，托珠单抗和阿巴西普用于治疗类风湿性关节炎，以前未使用可改变疾病的抗风湿药治疗，且仅在常规可改变疾病的抗风湿药治疗后：系统评价和经济评价
4. Deep radiomic prediction with clinical predictors of the survival in patients with rheumatoid arthritis-associated interstitial lung diseases [C] . Radin A. Nasirudin, Janne J. Nappi, Chinatsu Watari, SPIE Medical Imaging Conference . 2018

机译：类风湿关节炎相关性间质性肺疾病患者的深部放射学预测和生存期的临床预测
5. Rheumatoid arthritis and osteoarthritis synovial fibroblasts express FcalphaR (CD89) in vitro and in vivo: Implications for rheumatoid arthritis. [D] . Wover, Roberta Michelle Antoinette. 2006

机译：类风湿关节炎和骨关节炎滑膜成纤维细胞在体外和体内表达FcalphaR（CD89）：对类风湿关节炎的影响。
6. Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial [O] . Vappu Rantalaiho, Markku Korpela, Leena Laasonen, 2010

机译：早期组合疾病抗风湿药物治疗和严格的疾病控制改善了早期类风湿关节炎患者的长期放射学结局：芬兰类风湿关节炎联合疗法试验的11年结果
7. Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial [O] . Burmester, G. R., Mariette, X., Montecucco, C., 2007

机译：在临床实践中，单独使用阿达木单抗或与疾病缓解性抗风湿药合用治疗类风湿关节炎：活动性类风湿关节炎研究（ReAct）

Adalimumab alone and in combination with disease‐modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial

摘要

著录项

相似文献

相关主题

期刊订阅